BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32790362)

  • 1. Shell Disorder Analysis Suggests That Pangolins Offered a Window for a Silent Spread of an Attenuated SARS-CoV-2 Precursor among Humans.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    J Proteome Res; 2020 Nov; 19(11):4543-4552. PubMed ID: 32790362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Strategy for the Development of Vaccines for SARS-CoV-2 (COVID-19) and Other Viruses Using AI and Viral Shell Disorder.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    J Proteome Res; 2020 Nov; 19(11):4355-4363. PubMed ID: 33006287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    Microb Pathog; 2020 Jul; 144():104177. PubMed ID: 32244041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shell Disorder Models Detect That Omicron Has Harder Shells with Attenuation but Is Not a Descendant of the Wuhan-Hu-1 SARS-CoV-2.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study on the Nature of SARS-CoV-2 Using the Shell Disorder Models: Reproducibility, Evolution, Spread, and Attenuation.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.
    Xiao K; Zhai J; Feng Y; Zhou N; Zhang X; Zou JJ; Li N; Guo Y; Li X; Shen X; Zhang Z; Shu F; Huang W; Li Y; Zhang Z; Chen RA; Wu YJ; Peng SM; Huang M; Xie WJ; Cai QH; Hou FH; Chen W; Xiao L; Shen Y
    Nature; 2020 Jul; 583(7815):286-289. PubMed ID: 32380510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    J Proteome Res; 2022 Apr; 21(4):874-890. PubMed ID: 35142523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak.
    Zhang T; Wu Q; Zhang Z
    Curr Biol; 2020 Apr; 30(7):1346-1351.e2. PubMed ID: 32197085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins.
    Lam TT; Jia N; Zhang YW; Shum MH; Jiang JF; Zhu HC; Tong YG; Shi YX; Ni XB; Liao YS; Li WJ; Jiang BG; Wei W; Yuan TT; Zheng K; Cui XM; Li J; Pei GQ; Qiang X; Cheung WY; Li LF; Sun FF; Qin S; Huang JC; Leung GM; Holmes EC; Hu YL; Guan Y; Cao WC
    Nature; 2020 Jul; 583(7815):282-285. PubMed ID: 32218527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
    Liu P; Jiang JZ; Wan XF; Hua Y; Li L; Zhou J; Wang X; Hou F; Chen J; Zou J; Chen J
    PLoS Pathog; 2020 May; 16(5):e1008421. PubMed ID: 32407364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: animals, veterinary and zoonotic links.
    Tiwari R; Dhama K; Sharun K; Iqbal Yatoo M; Malik YS; Singh R; Michalak I; Sah R; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Vet Q; 2020 Dec; 40(1):169-182. PubMed ID: 32393111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32092911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    Li X; Zai J; Zhao Q; Nie Q; Li Y; Foley BT; Chaillon A
    J Med Virol; 2020 Jun; 92(6):602-611. PubMed ID: 32104911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
    J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of the vaccine development for SARS-CoV-2 and other viruses using the shell disorder analysis.
    Goh GK; Dunker AK; Foster JA; Uversky VN
    Pac Symp Biocomput; 2021; 26():143-153. PubMed ID: 33691012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
    Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
    Giri R; Bhardwaj T; Shegane M; Gehi BR; Kumar P; Gadhave K; Oldfield CJ; Uversky VN
    Cell Mol Life Sci; 2021 Feb; 78(4):1655-1688. PubMed ID: 32712910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.